Indivior Pharmaceuticals, Inc. INDV Stock-Based Comp
Stock-Based Comp at other companies
Segments
By segment
See fullOther financials
Where this comes from
Reported directly by Indivior Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ShareBasedCompensation.
The official record: Indivior Pharmaceuticals, Inc. ’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Indivior Pharmaceuticals, Inc. 's stock-based comp.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Indivior Pharmaceuticals, Inc. 's stock-based comp?
- Indivior Pharmaceuticals, Inc. (INDV) reported stock-based comp of $9M in Q1 2026.
- How has Indivior Pharmaceuticals, Inc. 's stock-based comp changed year-over-year?
- Indivior Pharmaceuticals, Inc. 's stock-based comp increased by 50.0% year-over-year, from $6M to $9M.
- What is the long-term trend for Indivior Pharmaceuticals, Inc. 's stock-based comp?
- Over 3 years (2022 to 2025), Indivior Pharmaceuticals, Inc. 's stock-based comp has grown at a 17.6% compound annual growth rate (CAGR), from $16M to $26M.
- What does stock-based comp mean?
- Total non-cash stock-based compensation expense for equity awards (RSUs, options, ESPP), added back to net income in cash flow reconciliation.